Insight Capital Research & Management’s Gilead Sciences GILD Stock Holding History

Insight Capital Research & Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-16,291	Closed	-$1.5M	–	111
2016 Q1	$1.5M	Sell	16,291 -11	-0.1%	-$992	0.46%	79
2015 Q4	$1.65M	Sell	16,302 -7,226	-31%	-$752K	0.48%	78
2015 Q3	$2.31M	Buy	+23,528	New	+$2.61M	0.7%	66
2015 Q1	–	Sell	-23,481	Closed	-$2.21M	–	123
2014 Q4	$2.21M	Sell	23,481 -39,765	-63%	-$4.11M	0.57%	78
2014 Q3	$6.73M	Buy	63,246 +29,028	+85%	+$2.84M	1.76%	12
2014 Q2	$2.84M	Sell	34,218 -777	-2%	-$60.5K	0.65%	63
2014 Q1	$2.48M	Buy	+34,995	New	+$2.74M	0.57%	68
2013 Q4	–	Sell	-37,635	Closed	-$2.68M	–	151
2013 Q3	$2.68M	Buy	37,635 +2,764	+8%	+$165K	0.65%	52
2013 Q2	$1.79M	Buy	+34,871	New	+$1.82M	0.46%	78

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Insight Capital Research & Management's GILD Position: Q2 2016 in Review

Insight Capital Research & Management sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 16,291 shares — an estimated $1.5M sold.

Insight Capital Research & Management first reported a position in GILD in Q2 2013 and held it in 9 quarters. The position peaked at $6.73M in Q3 2014. 1,596 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

Insight Capital Research & Management reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
Insight Capital Research & Management sold 16,291 Gilead Sciences shares in Q2 2016, an estimated $1.5M.
Insight Capital Research & Management first reported a position in Gilead Sciences in Q2 2013 and held it in 9 quarters.
Insight Capital Research & Management's Gilead Sciences position peaked at $6.73M in Q3 2014.
1,596 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Insight Capital Research & Management's 13F filing for Q2 2016, filed 27 Jul 2016.